These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 2895968
1. A comparison of serial E-RFC monitoring and immunomagnetic quantitation of CD2+ cells in RATG-treated transplant recipients. Brinchmann JE, Vartdal F, Forset KL, Thorsby E. Transplantation; 1988 Apr; 45(4):804-5. PubMed ID: 2895968 [No Abstract] [Full Text] [Related]
2. Immunologic monitoring of rabbit antithymocyte globulin-treated transplant recipients: a comparison of serial E-RFC and immunomagnetic quantitation of CD2+ cells. Brinchmann JE, Vartdal F, Forset KL, Thorsby E. Transplant Proc; 1988 Jun; 20(3):390-1. PubMed ID: 3289168 [No Abstract] [Full Text] [Related]
9. Comparison of the pharmacodynamics of two antilymphocyte preparations in renal allograft recipients. Turc-Baron C, Portalès P, Mourad G, Clot J. Transplant Proc; 1995 Aug; 27(4):2476. PubMed ID: 7652892 [No Abstract] [Full Text] [Related]
10. [Immunofluorescence tests versus rosette tests. Detection of receptors for the formation of rosettes with sheep erythrocytes using monoclonal antibodies OKT-11 and OKT-11A]. Koubek K, Herzog P. Cas Lek Cesk; 1983 Jan 14; 122(2):36-9. PubMed ID: 6337715 [No Abstract] [Full Text] [Related]
11. Rejection episodes and lymphocyte responses in patients treated with rabbit antithymocyte sera. Cardella CJ, Landsberg D, Ng CM. Transplant Proc; 1984 Aug 14; 16(4):1089-92. PubMed ID: 6235651 [No Abstract] [Full Text] [Related]
12. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine. Kawaguchi A, Szentpetery S, Mohanakumar T, Barnhart GR, Lower RR. J Heart Transplant; 1987 Aug 14; 6(4):214-7. PubMed ID: 3312532 [Abstract] [Full Text] [Related]
13. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month. Daudu P, Wright K, Geelhoed GW. Am Surg; 1980 Dec 14; 46(12):697-707. PubMed ID: 7004286 [Abstract] [Full Text] [Related]
14. New approaches to the use of antibodies for immunosuppression. Russell PS. Transplant Proc; 1982 Sep 14; 14(3):506-8. PubMed ID: 6758236 [No Abstract] [Full Text] [Related]
16. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. Andersen CB, Ladefoged SD, Larsen S. APMIS; 1994 Jan 14; 102(1):23-37. PubMed ID: 7513171 [Abstract] [Full Text] [Related]
18. Analysis of expression of CD2, CD3, and T cell antigen receptor molecules during early human fetal thymic development. Haynes BF, Singer KH, Denning SM, Martin ME. J Immunol; 1988 Dec 01; 141(11):3776-84. PubMed ID: 2903194 [Abstract] [Full Text] [Related]
19. RPA-2.10: an anti-CD2 monoclonal antibody that inhibits alloimmune responses and monitors T cell activation. Aversa GG, Bishop GA, Suranyi MG, Hall BM. Transplant Proc; 1987 Feb 01; 19(1 Pt 1):277-8. PubMed ID: 2908548 [No Abstract] [Full Text] [Related]
20. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA. Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977 [Abstract] [Full Text] [Related] Page: [Next] [New Search]